PRICE T ROWE ASSOCIATES INC /MD/ - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 69 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$296,000
-96.5%
81,136
-92.4%
0.00%
-100.0%
Q3 2021$8,572,000
+81.7%
1,068,812
+109.6%
0.00%
Q1 2021$4,718,000510,0000.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 831,625$7,693,0001.42%
BVF INC/IL 3,094,174$28,621,0001.07%
SECTORAL ASSET MANAGEMENT INC 647,556$5,990,0000.45%
Logos Global Management LP 470,000$4,348,0000.42%
AlphaCentric Advisors LLC 92,402$855,0000.29%
SILVERARC CAPITAL MANAGEMENT, LLC 28,570$264,0000.14%
Opaleye Management Inc. 103,600$958,0000.14%
Monashee Investment Management LLC 84,802$784,0000.12%
KETTLE HILL CAPITAL MANAGEMENT, LLC 93,900$869,0000.08%
Ikarian Capital, LLC 155,599$1,439,0000.05%
View complete list of VIRACTA THERAPEUTICS INC shareholders